SCHEMBL8286121

SCHEMBL8286121

O=C(Nc1ccccc1)Nc1cc(C(F)(F)F)c2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c2n1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.60
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
RAB9A P51151 3/20 0.39
NPC1 O15118 2/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
MAPT P10636 2/20 0.38
HTT P42858 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
KCNJ6 P48051 4/20 0.37
KCNJ5 P48544 4/20 0.37
KCNJ3 P48549 4/20 0.37
AURKB Q96GD4 2/20 0.37
MAPK13 O15264 1/20 0.37
MAPK12 P53778 1/20 0.37
MAPK11 Q15759 1/20 0.37
MAPK14 Q16539 1/20 0.37
TSHR P16473 1/20 0.36
EPHA3 P29320 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286113 0.90 PDE11A (0.60) PDE11AMEN1KMT2ARAB9ANPC1
SCHEMBL8286116 0.90 PDE11A (0.56) PDE11AMEN1KMT2ACNR1CNR2
SCHEMBL8286117 0.89 PDE11A (0.59) PDE11AMEN1KMT2ARAB9ANPC1
SCHEMBL8285152 0.87 PDE11A (0.56) PDE11AMEN1KMT2ANPC1CNR1
SCHEMBL8287114 0.85 PDE11A (0.59) PDE11AMEN1KMT2ACNR1CNR2
SCHEMBL8287838 0.84 PDE11A (0.57) PDE11AMEN1KMT2ACNR1CNR2
SCHEMBL8285196 0.84 PDE11A (0.64) PDE11AMEN1KMT2ACNR1CNR2
SCHEMBL8286369 0.83 PDE11A (0.59) PDE11AMEN1KMT2ACNR1CNR2
SCHEMBL8285159 0.83 PDE11A (0.53) PDE11AMEN1KMT2AMAPTHTT
SCHEMBL8285142 0.82 PDE11A (0.60) PDE11AMEN1KMT2AMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed